• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新冠疫情的影响：弥合新冠疫苗犹豫与有效性之间现有差距的科学方法

COVID-19 Ramifications: A Scientific Approach to Bridge the Existing Gap between COVID Vaccines Hesitancy and Effectiveness.

作者信息

Nagy Hassan, Hameed Maha, Khan Faryal, Co Edzel Lorraine, Rauf Unaiza

机构信息

Division of Research & Academic Affairs, Larkin Health System, South Miami, Florida, United States.

出版信息

Avicenna J Med. 2023 Jan 13;13(1):15-22. doi: 10.1055/s-0042-1760338. eCollection 2023 Jan.

DOI:10.1055/s-0042-1760338
PMID:36969353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10038754/
Abstract

The 2019 coronavirus disease (COVID-19) has been a major dilemma all over the world since December 2019. Several types of COVID-19 vaccines were developed for public utilization to halt the widespread of the disease; however, vaccine hesitancy is one major factor that prevents a successful control of this pandemic. This study aimed to summarize the different kinds of available COVID-19 vaccines and their effectiveness, and to assess the associated factors regarding vaccine hesitancy of the general population to bridge the gap existing between the two factors. 1 3.

摘要

自2019年12月以来，2019冠状病毒病（COVID-19）一直是全球面临的一个重大难题。为了阻止该疾病的传播，人们研发了几种类型的COVID-19疫苗供公众使用；然而，疫苗犹豫是阻碍成功控制这一疫情的一个主要因素。本研究旨在总结现有的不同种类的COVID-19疫苗及其有效性，并评估普通人群疫苗犹豫的相关因素，以弥合这两个因素之间存在的差距。 1 3.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/252970f89e72/10-1055-s-0042-1760338-i220107-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/6371c968182f/10-1055-s-0042-1760338-i220107-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/d3a36e19efa5/10-1055-s-0042-1760338-i220107-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/2977c988d3db/10-1055-s-0042-1760338-i220107-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/252970f89e72/10-1055-s-0042-1760338-i220107-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/6371c968182f/10-1055-s-0042-1760338-i220107-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/d3a36e19efa5/10-1055-s-0042-1760338-i220107-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/2977c988d3db/10-1055-s-0042-1760338-i220107-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/860f/10038754/252970f89e72/10-1055-s-0042-1760338-i220107-4.jpg

相似文献

1
COVID-19 Ramifications: A Scientific Approach to Bridge the Existing Gap between COVID Vaccines Hesitancy and Effectiveness.新冠疫情的影响：弥合新冠疫苗犹豫与有效性之间现有差距的科学方法
Avicenna J Med. 2023 Jan 13;13(1):15-22. doi: 10.1055/s-0042-1760338. eCollection 2023 Jan.
2
Hesitancy in COVID-19 vaccine uptake and its associated factors among the general adult population: a cross-sectional study in six Southeast Asian countries.普通成年人群中新冠病毒疫苗接种犹豫及其相关因素：一项对六个东南亚国家的横断面研究
Trop Med Health. 2022 Jan 5;50(1):4. doi: 10.1186/s41182-021-00393-1.
3
COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake.COVID-19 疫苗犹豫：对犹豫的考虑因素和提高疫苗接种率。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2062972. doi: 10.1080/21645515.2022.2062972. Epub 2022 Apr 18.
4
COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey.科威特公众对 COVID-19 疫苗的犹豫：一项横断面调查。
Int J Environ Res Public Health. 2021 Aug 22;18(16):8836. doi: 10.3390/ijerph18168836.
5
Coronavirus conspiracy suspicions, general vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic.新冠病毒阴谋论怀疑、一般疫苗态度、信任和新冠病毒信息来源对英国居民在 COVID-19 大流行期间疫苗犹豫的预测。
Psychol Med. 2023 Jan;53(1):236-247. doi: 10.1017/S0033291721001434. Epub 2021 Apr 12.
6
COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan.COVID-19 疫苗犹豫和疫苗护照：日本的一项横断面联合实验。
BMJ Open. 2022 Jun 16;12(6):e060829. doi: 10.1136/bmjopen-2022-060829.
7
COVID-19 and influenza vaccine hesitancy among college students.大学生对 COVID-19 和流感疫苗的犹豫。
J Am Pharm Assoc (2003). 2021 Nov-Dec;61(6):709-714.e1. doi: 10.1016/j.japh.2021.05.009. Epub 2021 May 21.
8
Lack of Access to Coronavirus Disease 2019 Vaccines Could Be a Greater Threat than Vaccine Hesitancy in Low-Income and Conflict Nations: The Case of Yemen.在低收入和冲突国家，无法获得 2019 年冠状病毒病疫苗可能比疫苗犹豫带来更大的威胁：以也门为例。
Clin Infect Dis. 2022 Nov 14;75(10):1827-1833. doi: 10.1093/cid/ciac088.
9
Vaccine hesitancy and post-vaccination adherence to safety measures: A mixed-method study.疫苗犹豫和接种后安全措施的依从性：一项混合方法研究。
Front Public Health. 2023 Mar 31;11:1072740. doi: 10.3389/fpubh.2023.1072740. eCollection 2023.
10
COVID-19 vaccine hesitancy in Africa: a scoping review.非洲的 COVID-19 疫苗犹豫：范围综述。
Glob Health Res Policy. 2022 Jul 19;7(1):21. doi: 10.1186/s41256-022-00255-1.

本文引用的文献

1
Review of COVID-19 vaccine subtypes, efficacy and geographical distributions.新型冠状病毒疫苗亚型、疗效和地理分布综述。
Postgrad Med J. 2022 May 1;98(1159):389-394. doi: 10.1136/postgradmedj-2021-140654.
2
Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran.在伊朗医护人员中接种卫星 V 型 COVID-19 疫苗后的副作用和免疫原性。
Sci Rep. 2021 Nov 2;11(1):21464. doi: 10.1038/s41598-021-00963-7.
3
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021.
COVID-19 疫苗对 Delta（B.1.617.2）变异株感染的有效性：2021 年 1 月 1 日至 8 月 25 日期间一项实时系统评价和荟萃分析的第二次中期结果。
Euro Surveill. 2021 Oct;26(41). doi: 10.2807/1560-7917.ES.2021.26.41.2100920.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.辉瑞-BioNTech 信使核糖核酸新冠病毒疫苗 6 个月的安全性和有效性
N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15.
5
Controversy surrounding the Sputnik V vaccine.关于卫星 V 疫苗的争议。
Respir Med. 2021 Oct;187:106569. doi: 10.1016/j.rmed.2021.106569. Epub 2021 Aug 10.
6
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen（强生）和 mRNA COVID-19 疫苗（辉瑞-生物科技和莫德纳）成年受种者发生不良事件后使用 COVID-19 疫苗：免疫实践咨询委员会的更新-美国，2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
7
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis.COVID-19 的 50 多种长期影响：系统评价和荟萃分析。
Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8.
8
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.对 COVID-19 疫苗的疗效和安全性进行全面分析。
Mol Ther. 2021 Sep 1;29(9):2794-2805. doi: 10.1016/j.ymthe.2021.08.001. Epub 2021 Aug 6.
9
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2（德尔塔）变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
10
Myocarditis With COVID-19 mRNA Vaccines.COVID-19 mRNA 疫苗相关心肌炎。
Circulation. 2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul 20.